Looking for a Ziagen lawyer in District of Columbia? Get in touch with one of our Ziagen lawyers in District of Columbia now.

Ziagen - MSN Newsfeeds

Lactic acidosis / acidaemia
Aidsmap - Combined use of 3TC with abacavir ( Ziagen ) or d4T was associated with a reduced risk of hyperlactatemia compared to d4T and ddI (Moyle 2002). The nucleotide analogue reverse transcriptase inhibitor tenofovir ( Viread ), combined with ddI or ddI and d4T ...
FDA warns of HIV drug mix-up
United Press International - WASHINGTON April 12 (UPI) -- The U.S. Food and Drug Administration said Thursday that bottles of HIV drug Ziagen may have been mislabeled as Combivir, another HIV drug. The FDA and GlaxoSmithKline, which makes both drugs, said it appears the bottles ...
Upcoming and ongoing Volunteer Opportunities events
San Francisco Weekly - Emtriva 200mg, Viread 300mg, and Ziagen 300mg are sought by this organization, which collects and redistributes medications no longer needed by those for whom they were prescribed. Call or visit Web site for information. Date/Time: Daily from Mon ...
USP Publishes Standards For Medications For Neglected Diseases
Medical News Today - Abacavir Sulfate, and Efavirenz. These monographs are posted in draft form, with a 90-day period for public comment that ends on April 30, 2007. Instructions for submitting comments are at http://www.usp.org/internationalStandards/ . Monographs ...
Is genetic screening for abacavir hypersensitivity risk appropriate ...
Aidsmap - Recent studies from Australia and Brighton have suggested that screening for the B*5701 gene may be a useful tool to help prevent the hypersensitivity reaction to the nucleoside analogue drug, abacavir ( Ziagen , also found in Kivexa / Epzicom and Trizivir ...
New data reinforce efficacy of Trizivir® alone in treatment-naïve ...
WebWire - Trizivir is one of multiple products containing abacavir sulfate, also known as Ziagen . Before starting a patient on Trizivir, physicians should review medical history for prior exposure to any abacavir-containing product in order to avoid ...
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive ...
WTOL-TV - TRIZIVIR is one of multiple products containing abacavir sulfate, also known as ZIAGEN. Before starting a patient on TRIZIVIR, physicians should review medical history for prior exposure to any abacavir-containing product in order to avoid ...
Renal (kidney) disease
Aidsmap - A Canadian study of approximately 900 people with normal kidney function who started either tenofovir or abacavir ( Ziagen ) found that people who began tenofovir had more than twice the risk of creatinine elevation compared with those who started ...
GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug ...
PR Newswire - Patients were randomized to receive either LEXIVA/r or lopinavir/r twice daily, administered with EPZICOM(TM) (abacavir sulfate and lamivudine) once daily. Study results at 48 weeks showed that an HIV regimen containing LEXIVA/r administered twice ...
Suspected abacavir hypersensitivity less likely to be diagnosed in ...
Aidsmap - People of African ethnicity have a lower reported rate of suspected hypersensivity reaction (HSR) to the nucleoside analogue, abacavir ( Ziagen ), according to an analysis of five clinical trials that included the drug. However, the analysis ...
Study Shows TRIZIVIR Alone to be Comparable to Regimen Including ...
WATE - TRIZIVIR is one of multiple products containing abacavir sulfate, also known as ZIAGEN. Before starting a patient on TRIZIVIR, physicians should review medical history for prior exposure to any abacavir-containing product in order to avoid ...
U climbing ladder in research rankings
Minnesota Daily - Ziagen, a pharmaceutical drug used to treat AIDS, generated significant revenue for the University, Mulcahy said. "Across the board, developments in biomedical devices and medicine have been the most consistent areas of success," he said, naming ...
Report says U of M does well at moving inventions to market
Duluth News Tribune - According to university officials and the report's chief author, the sixth-place ranking comes from income related to computer software products developed at the university and a windfall from the AIDS-fighting drug Ziagen, among other things. Mulcahy ...
New Apple Could Bring Zesty Royalties To 'U'
WCCO - The Honeycrisp apple, for example, has generated $4 million in its lifetime, making it one of the 10 highest revenue producers at the university. (The university's most-profitable invention is an HIV drug sold under the commercial name Ziagen, among ...
GSK to supply antiretroviral drugs to Russia at discounted price
News-Medical.Net - GlaxoSmithKline has announced it would supply 90,000 packs of its antiretroviral drugs Combivir, Epivir and Ziagen to Russia at discounted prices by the end of 2006, the AFP/Yahoo! U.K and Ireland reports (AFP/Yahoo! U.K and Ireland, 9/15). The ...
Power Machines' New CEO
Moscow Times - ... working to provide treatment to 15,000 patients this year. It is the first time the government has purchased anti-retroviral treatments for the disease, Glaxo said Friday. The company will sell 90,000 treatment packs of the Combivir, Epivir and Ziagen ...
GlaxoSmithKline offers cheap HIV drugs to Russia
Zee News - Combivir, Epivir and Ziagen, by the end of 2006," the British company said. The agreement was the first direct, federal purchase of anti-retroviral medicines in Russia, GSK said, without stating the cost of the drugs. "Today's agreement will ...
Glaxo backs Russian HIV/Aids crusade
IC Wales - Glaxo will supply more than 90,000 treatment packs of its drugs - Combivir, Epivir and Ziagen - to the Russian Government by the end of 2006. These medicines, which are used as mainstay treatment for HIV, will be dispensed by hospital centres across ...
Glaxo to supply cut-price AIDS drugs to Russia
Reuters UK - ... that it is more interested in profits than patients. The Glaxo deal is the first direct, federal purchase of anti-retroviral medicines in Russia and covers the supply of over 90,000 treatment packs of Glaxo's drugs Combivir, Epivir and Ziagen by the ...
Business News In Brief
Sheffield Today - ... that it is more interested in profits than patients. The Glaxo deal is the first direct, federal purchase of anti-retroviral medicines in Russia and covers the supply of over 90,000 treatment packs of Glaxo's drugs Combivir, Epivir and Ziagen by the ...
Looking for a Ziagen lawyer in District of Columbia? Get in touch with one of our Ziagen lawyers in District of Columbia now.

Pages:   1   2   Next

AddThis Social Bookmark Button

 

Need A Ziagen Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Ziagen Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Ziagen Case - Submit Your Information Below

Do you need legal assistance with your Ziagen case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Ziagen Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.